Notably, we identified putative agonist sequences from the linear heptapeptide (X 7 ) and the heptapeptide (CX 5 C) library but not from the hexapeptide library (CX 4 C)
UK dosing schedules, per BNF and NICE CKS, are as follows: Without neurological involvement: 1 mg IM three times a week for 2 weeks, then 1 mg IM every 23 months [14] [15] With neurological involvement: 1 mg IM on alternate days until no further improvement, then 1 mg IM every 2 months Patients should not self-initiate supplementation without first discussing it with their GP or prescribing clinician
Article 5 mins 3 Ways to Manage Business Interruption During Uncertain Times With increasing global uncertainty, businesses should focus on emerging threats and decide how to best address them
Annu Rev Pharmacol Toxicol 48:495535
Kolczynska K, Loza-Valdes A, Hawro I, et al